These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12426692)

  • 1. Concentration of soluble CD44 standard and soluble CD44 variant V5 in the serum of patients with malignant bone tumors.
    Holzer G; Kittl E; Pfandelsteiner T; Trieb K; Kotz R
    Med Pediatr Oncol; 2003 Jan; 40(1):64-5. PubMed ID: 12426692
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-immunological studies of 32 cases of bone tumors].
    Franchi F; Russo V; Luzi G; Santori FS; De Chiara N; Aiuti F
    Minerva Med; 1980 Jun; 71(25):1815-22. PubMed ID: 6968049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunofluorescence tests on sera of patients with osteogenic sarcoma.
    Priori ES; Wilbur JR; Dmochowski L
    J Natl Cancer Inst; 1971 Jun; 46(6):1299-308. PubMed ID: 4932429
    [No Abstract]   [Full Text] [Related]  

  • 4. Are serum levels of CD44 relevant in children with pediatric sarcomas?
    Kebudi R; Ayan I; Yasasever V; Demokan S; Görgün O
    Pediatr Blood Cancer; 2006 Jan; 46(1):62-5. PubMed ID: 16155927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
    Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum antibodies against the heat shock protein 60 are elevated in patients with osteosarcoma.
    Trieb K; Gerth R; Windhager R; Grohs JG; Holzer G; Berger P; Kotz R
    Immunobiology; 2000 Jan; 201(3-4):368-76. PubMed ID: 10776793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunological study in carcinogenesis. Distribution of tissue incompatibility antigens (system HL-A) in oncological patients].
    Govallo VI; Shelepina TA
    Vopr Onkol; 1975; 21(9):13-9. PubMed ID: 1059274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of the immunohematologic status of patients with malignant bone neoplasms].
    Zhukovskiĭ IIa; Bizer VA
    Ter Arkh; 1978; 50(7):95-7. PubMed ID: 362593
    [No Abstract]   [Full Text] [Related]  

  • 9. [Selected immunologic indicators in malignant bone tumors].
    Keleová A; Huraj E; Jahnová E; Janota S; Nyulassy S
    Acta Chir Orthop Traumatol Cech; 1990 Feb; 57(1):77-88. PubMed ID: 2336911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of cellular immunity indices in patients with malignant tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA
    Vopr Onkol; 1973; 19(11):18-21. PubMed ID: 4522541
    [No Abstract]   [Full Text] [Related]  

  • 11. The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer.
    Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Fanucchi A; Prontera C; Bianchi R; Genazzani AR
    Anticancer Res; 1998; 18(1B):537-9. PubMed ID: 9568174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Ozeki A; Kokatsu T; Kubota A; Furukawa M; Tsukuda M
    Acta Otolaryngol; 2005 Apr; 125(4):392-7. PubMed ID: 15823810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. sCD30 and sCD40L detection in patients with osteosarcoma, chondrosarcoma and Ewing sarcoma.
    Solooki S; Khozaei A; Shamsdin SA; Emami MJ; Khademolhosseini F
    Iran J Immunol; 2013 Dec; 10(4):229-37. PubMed ID: 24375064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report.
    Damron TA; Ward WG; Stewart A
    Clin Orthop Relat Res; 2007 Jun; 459():40-7. PubMed ID: 17414166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating antibodies in human connective tissue malignancy.
    Moore M; Hughes LA
    Br J Cancer Suppl; 1973 Aug; 1():175-84. PubMed ID: 4613373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble p185(HER-2) in patients with malignant bone tumours.
    Holzer G; Pfandlsteiner T; Koschat M; Noske H; Trieb K; Kotz R
    Pediatr Blood Cancer; 2005 Feb; 44(2):163-6. PubMed ID: 15468309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
    Bloom ET
    Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum levels of TNF-beta and sTNF-R in patients with malignant bone tumours.
    Holzer G; Pfandlsteiner T; Blahovec H; Trieb K; Kotz R
    Anticancer Res; 2003; 23(3C):3057-9. PubMed ID: 12926161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteosarcoma and Ewing's sarcoma in children and adolescents: retrospective clinicopathological study.
    Ilić I; Manojlović S; Cepulić M; Orlić D; Seiwerth S
    Croat Med J; 2004 Dec; 45(6):740-5. PubMed ID: 15578809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.